Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marilyn Lilun Moy, M.D.

Co-Author

This page shows the publications co-authored by Marilyn Moy and Eric Garshick.
Connection Strength

4.400
  1. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD. Chest. 2014 Mar 01; 145(3):542-550.
    View in: PubMed
    Score: 0.568
  2. An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014 Feb; 11(2):149-57.
    View in: PubMed
    Score: 0.565
  3. Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One. 2013; 8(4):e60400.
    View in: PubMed
    Score: 0.534
  4. Daily step counts in a US cohort with COPD. Respir Med. 2012 Jul; 106(7):962-9.
    View in: PubMed
    Score: 0.500
  5. Free-living physical activity in COPD: assessment with accelerometer and activity checklist. J Rehabil Res Dev. 2009; 46(2):277-86.
    View in: PubMed
    Score: 0.397
  6. Respiratory symptoms and intensity of occupational dust exposure. Int Arch Occup Environ Health. 2004 Oct; 77(7):515-20.
    View in: PubMed
    Score: 0.295
  7. Molecular markers of aging, exercise capacity, & physical activity in COPD. Respir Med. 2021 10; 187:106576.
    View in: PubMed
    Score: 0.238
  8. Long-term effects of web-based pedometer-mediated intervention on COPD exacerbations. Respir Med. 2020 02; 162:105878.
    View in: PubMed
    Score: 0.213
  9. Effects of Indoor and Ambient Black Carbon and [Formula: see text] on Pulmonary Function among Individuals with COPD. Environ Health Perspect. 2018 12; 126(12):127008.
    View in: PubMed
    Score: 0.198
  10. Indoor black carbon and biomarkers of systemic inflammation and endothelial activation in COPD patients. Environ Res. 2018 08; 165:358-364.
    View in: PubMed
    Score: 0.190
  11. Indoor black carbon of outdoor origin and oxidative stress biomarkers in patients with chronic obstructive pulmonary disease. Environ Int. 2018 06; 115:188-195.
    View in: PubMed
    Score: 0.188
  12. Promoting physical activity in COPD: Insights from a randomized trial of a web-based intervention and pedometer use. Respir Med. 2017 Sep; 130:102-110.
    View in: PubMed
    Score: 0.180
  13. Use of pedometer and Internet-mediated walking program in patients with chronic obstructive pulmonary disease. J Rehabil Res Dev. 2010; 47(5):485-96.
    View in: PubMed
    Score: 0.106
  14. Multivariate models of determinants of health-related quality of life in severe chronic obstructive pulmonary disease. J Rehabil Res Dev. 2009; 46(5):643-54.
    View in: PubMed
    Score: 0.099
  15. Accuracy of uniaxial accelerometer in chronic obstructive pulmonary disease. J Rehabil Res Dev. 2008; 45(4):611-7.
    View in: PubMed
    Score: 0.093
  16. Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trial. Pulm Circ. 2013 Dec; 3(4):889-97.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.